Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Martinez-Moreno, M; Leiva, M; Aguilera-Montilla, N; Sevilla-Movilla, S; de Val, SI; Arellano-Sanchez, N; Gutierrez, NC; Maldonado, R; Martinez-Lopez, J; Buno, I; Garcia-Marco, JA; Sanchez-Mateos, P; Hidalgo, A; Garcia-Pardo, A; Teixido, J.

In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by alpha 4 beta 1 cytoplasmic-binding proteins

LEUKEMIA. 2016; 30(4): 861-872 Nº de citas: 34 [doi:10.1038/leu.2015.332]

Forero-Castro, M; Robledo, C; Lumbreras, E; Benito, R; Hernandez-Sanchez, JM; Hernandez-Sanchez, M; Garcia, JL; Corchete-Sanchez, LA; Tormo, M; Barba, P; Menarguez, J; Ribera, J; Grande, C; Escoda, L; Olivier, C; Carrillo, E; de Coca, AG; Ribera, JM; Hernandez-Rivas, JM.

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

BRITISH JOURNAL OF HAEMATOLOGY. 2016; 172(3): 428-438 Nº de citas: 22 [doi:10.1111/bjh.13849]

Escudero-Vilaplana, V; Garcia-Gonzalez, X; Osorio-Prendes, S; Romero-Jimenez, RM; Sanjurjo-Saez, M.

Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2016; 41(1): 59-63 Nº de citas: 8 [doi:10.1111/jcpt.12348]

Pinana, JL; Sanz, J; Esquirol, A; Martino, R; Picardi, A; Barba, P; Parody, R; Gayoso, J; Montesinos, P; Guidi, S; Terol, MJ; Moscardo, F; Solano, C; Arcese, W; Sanz, MA; Sierra, J; Sanz, G.

Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(2): 128-135 Nº de citas: 14 [doi:10.1111/ejh.12557]

Mateos, MV; Martinez-Lopez, J; Hernandez, MT; Ocio, EM; Rosinol, L; Martinez, R; Teruel, AI; Gutierrez, NC; Ramos, MLM; Oriol, A; Bargay, J; Bengoechea, E; Gonzalez, Y; de Oteyza, JP; Gironella, M; Encinas, C; Martin, J; Cabrera, C; Paiva, B; Cedena, MT; Puig, N; Blade, J; Lahuerta, JJ; San-Miguel, J.

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM

BLOOD. 2016; 127(4): 420-425 Nº de citas: 54 [doi:10.1182/blood-2015-08-666537]

Kelleher, N; Garcia, O; Gallardo, D; Gonzalez-Campos, J; Hernandez-Rivas, JM; Montesinos, P; Sarra, J; Gil, C; Barba, P; Guardia, R; Brunet, S; Bernal, T; Martinez, MP; Abella, E; Bermudez, A; Sanchez-Delgado, M; Antonia, C; Gayoso, J; Calbacho, M; Ribera, JM.

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

LEUKEMIA & LYMPHOMA. 2016; 57(1): 86-91 Nº de citas: 17 [doi:10.3109/10428194.2015.1040013]

Medin, G; Garcia-Navarro, C; Gomez, MN; Amador, JTR; Mellado, MJ; Jimenez, S; Munoz-Fernandez, MA; Conejo, PR; Saavedra, J; Hortelano, MG; Guillen, S; Gonzalez-Tome, MI.

Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 2016; 28(1): 124-130 Nº de citas: 19 [doi:10.1080/09540121.2015.1071768]

Perez-Chacon, G; Martinez-Laperche, C; Rebolleda, N; Somovilla-Crespo, B; Munoz-Calleja, C; Buno, I; Zapata, JM.

Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances

CLINICAL CANCER RESEARCH. 2016; 22(1): 134-145 Nº de citas: 10 [doi:10.1158/1078-0432.CCR-15-0736]

Navarro, D; Amat, P; de la Camara, R; Lopez, J; Vazquez, L; Serrano, D; Nieto, J; Rovira, M; Pinana, JL; Gimenez, E; Solano, C.

Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients

Open Forum Infectious Diseases. 2016; 3(2): Nº de citas: 38 [doi:10.1093/ofid/ofw107]

Garcia-Morin, M; Lopez-Sanguos, C; Vazquez, P; Alvarez, T; Maranon, R; HUERTA ARAGONÉS, JORGE; CELA DE JULIÁN, ELENA.

Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department

HEMOGLOBIN. 2016; 40(6): 388-391 Nº de citas: 9 [doi:10.1080/03630269.2016.1275677]

Marin, JJG; Briz, O; Rodriguez-Macias, G; Diez-Martin, JL; Macias, RIR.

Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

BLOOD REVIEWS. 2016; 30(1): 55-64 Nº de citas: 42 [doi:10.1016/j.blre.2015.08.001]

Santos, N; Rodriguez-Romanos, R; Nieto, JB; Buno, I; Vallejo, C; Jimenez-Velasco, A; Brunet, S; Buces, E; Lopez-Jimenez, J; Gonzalez, M; Ferra, C; Sampol, A; de la Camara, R; Martinez, C; Gallardo, D.

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation

BONE MARROW TRANSPLANTATION. 2016; 51(1): 79-82 Nº de citas: 9 [doi:10.1038/bmt.2015.207]

Sanchez-Castro, J; Marco-Betes, V; Gomez-Arbones, X; Garcia-Cerecedo, T; Lopez, R; Talavera, E; Fernandez-Ruiz, S; Adema, V; Marugan, I; Luno, E; Sanzo, C; Vallespi, T; Arenillas, L; Marco-Buades, J; Batlle, A; Buno, I; Martin-Ramos, ML; Blazquez-Rios, B; Collado-Nieto, R; Vargas, MT; Gonzalez-Martinez, T; Sanz, G; Sole, F.

Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

LEUKEMIA & LYMPHOMA. 2015; 56(11): 3183-3188 Nº de citas: 4 [doi:10.3109/10428194.2015.1028053]

Olmedo, C; Buno, I; Pla, R; Lomba, I; Bardinet, T; Banares, R.

Managing a health research institute: towards research excellence through continuous improvement

Gaceta Sanitaria. 2015; 29(6): 458-460 Nº de citas: 3 [doi:10.1016/j.gaceta.2015.06.003]

Noriega, V; Martinez-Laperche, C; Buces, E; Pion, M; Sanchez-Hernandez, N; Martin-Antonio, B; Guillem, V; Bosch-Vizcaya, A; Bento, L; Gonzalez-Rivera, M; Balsalobre, P; Kwon, M; Serrano, D; Gayoso, J; de la Camara, R; Brunet, S; Rojas-Contreras, R; Nieto, JB; Martinez, C; Gonzalez, M; Espigado, I; Vallejo, JC; Sampol, A; Jimenez-Velasco, A; Urbano-Ispizua, A; Solano, C; Gallardo, D; Diez-Martin, JL; Buno, I.

The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

PLoS One. 2015; 10(10): Nº de citas: 10 [doi:10.1371/journal.pone.0140454]

Olmedo C; Plá R; Bellón JM; Bardinet T; Buño I; Bañares R.

La investigación biomédica hospitalaria a través de la satisfacción de los profesionales de un Instituto de Investigación Sanitaria.

Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial. 2015; 30(5): 265-272 Nº de citas: 1 [doi:10.1016/j.cali.2015.05.001]

Sanchez, PL; Fernandez-Santos, ME; Costanza, S; Climent, AM; Moscoso, I; Gonzalez-Nicolas, MA; Sanz-Ruiz, R; Rodriguez, H; Kren, SM; Garrido, G; Escalante, JL; Bermejo, J; Elizaga, J; Menarguez, J; Yotti, R; del Villar, CP; Espinosa, MA; Guillem, MS; Willerson, JT; Bernad, A; Matesanz, R; Taylor, DA; Fernandez-Aviles, F.

Acellular human heart matrix: A critical step toward whole heart grafts

BIOMATERIALS. 2015; 61: 279-289 Nº de citas: 159 [doi:10.1016/j.biomaterials.2015.04.056]

Casado, LF; Garcia-Gutierrez, JV; Massague, I; Giraldo, P; Perez-Encinas, M; de Paz, R; Martinez-Lopez, J; Bautista, G; Osorio, S; Requena, MJ; Palomera, L; Penarrubia, MJ; Calle, C; Hernandez-Rivas, JA; Burgaleta, C; Maestro, B; Garcia-Ormena, N; Steegmann, JL.

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months

Cancer Medicine. 2015; 4(7): 995-1002 Nº de citas: 8 [doi:10.1002/cam4.440]